Apellis Pharmaceuticals Statistics
Total Valuation
APLS has a market cap or net worth of $5.79 billion. The enterprise value is $5.78 billion.
| Market Cap | 5.79B |
| Enterprise Value | 5.78B |
Important Dates
The next confirmed earnings date is Tuesday, May 7, 2024, before market open.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
APLS has 120.58 million shares outstanding. The number of shares has increased by 11.84% in one year.
| Shares Outstanding | 120.58M |
| Shares Change (YoY) | +11.84% |
| Shares Change (QoQ) | +0.78% |
| Owned by Insiders (%) | 13.22% |
| Owned by Institutions (%) | 96.02% |
| Float | 81.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.18 |
| Forward PS | 7.42 |
| PB Ratio | 30.95 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 14.57 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.10, with a Debt / Equity ratio of 0.57.
| Current Ratio | 3.10 |
| Quick Ratio | 2.26 |
| Debt / Equity | 0.57 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -16.80 |
Financial Efficiency
Return on equity (ROE) is -178.50% and return on invested capital (ROIC) is -169.30%.
| Return on Equity (ROE) | -178.50% |
| Return on Assets (ROA) | -60.40% |
| Return on Capital (ROIC) | -169.30% |
| Revenue Per Employee | $564,944 |
| Profits Per Employee | -$753,031 |
| Employee Count | 702 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 0.50 |
Taxes
In the past 12 months, APLS has paid $2.13 million in taxes.
| Income Tax | 2.13M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.75% in the last 52 weeks. The beta is 0.89, so APLS's price volatility has been lower than the market average.
| Beta (1Y) | 0.89 |
| 52-Week Price Change | -43.75% |
| 50-Day Moving Average | 58.73 |
| 200-Day Moving Average | 51.82 |
| Relative Strength Index (RSI) | 38.32 |
| Average Volume (30 Days) | 1,328,296 |
Short Selling Information
The latest short interest is 10.44 million, so 8.66% of the outstanding shares have been sold short.
| Short Interest | 10.44M |
| Short Previous Month | 10.59M |
| Short % of Shares Out | 8.66% |
| Short % of Float | 12.88% |
| Short Ratio (days to cover) | 7.76 |
Income Statement
In the last 12 months, APLS had revenue of $396.59 million and -$528.63 million in losses. Loss per share was -$4.45.
| Revenue | 396.59M |
| Gross Profit | 338.08M |
| Operating Income | -517.12M |
| Pretax Income | -526.50M |
| Net Income | -528.63M |
| EBITDA | -495.21M |
| EBIT | -496.92M |
| Loss Per Share | -$4.45 |
Balance Sheet
The company has $352.30 million in cash and $110.93 million in debt, giving a net cash position of $241.37 million or $2.00 per share.
| Cash & Cash Equivalents | 352.30M |
| Total Debt | 110.93M |
| Net Cash | 241.37M |
| Net Cash Per Share | $2.00 |
| Equity / Book Value | 194.52M |
| Book Value Per Share | 1.61 |
| Working Capital | 518.74M |
Cash Flow
In the last 12 months, operating cash flow was -$594.74 million and capital expenditures -$674,000, giving a free cash flow of -$595.41 million.
| Operating Cash Flow | -594.74M |
| Capital Expenditures | -674,000 |
| Free Cash Flow | -595.41M |
| FCF Per Share | -$5.02 |
Margins
Gross margin is 85.25%, with operating and profit margins of -130.39% and -133.29%.
| Gross Margin | 85.25% |
| Operating Margin | -130.39% |
| Pretax Margin | -132.76% |
| Profit Margin | -133.29% |
| EBITDA Margin | -124.87% |
| EBIT Margin | -125.30% |
| FCF Margin | -150.13% |
Dividends & Yields
APLS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.84% |
| Shareholder Yield | -11.84% |
| Earnings Yield | -8.78% |
| FCF Yield | -9.89% |
Analyst Forecast
The average price target for APLS is $76.24, which is 59.02% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $76.24 |
| Price Target Difference | 59.02% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 40.69% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
APLS has an Altman Z-Score of 0.26 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.26 |
| Piotroski F-Score | 2 |